Jan Šilhán (Jan Silhan)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Ischemia Reperfusion Injury

Intellectual Disability

Top Venues

Nature communications

Nucleic acids research

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Šilhán, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, Jan Kozic, Radim Nencka, Evzen Boura
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature communications 14 (1) (2023)
Jan Šilhán, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, Jan Kozic, Radim Nencka, Evzen Boura
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature communications 14 (1) (2023)
Jan Šilhán, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, Jan Kozic, Radim Nencka, Evzen Boura
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature communications 14 (1) (2023)
Jan Šilhán, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, Jan Kozic, Radim Nencka, Evzen Boura
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature communications 14 (1) (2023)
Jan Šilhán, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, Jan Kozic, Radim Nencka, Evzen Boura
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature communications 14 (1) (2023)
Jan Šilhán, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, Jan Kozic, Radim Nencka, Evzen Boura
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature communications 14 (1) (2023)
Jan Šilhán, Martin Klima, Tomas Otava, Petr Skvara, Dominika Chalupska, Karel Chalupsky, Jan Kozic, Radim Nencka, Evzen Boura
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature communications 14 (1) (2023)
Radim Nencka, Jan Šilhán, Martin Klima, Tomas Otava, Hugo Kocek, Petra Krafcikova, Evzen Boura
Coronaviral RNA-methyltransferases: function, structure and inhibition. Nucleic acids research 50 (2) (2022)
Andrea Huskova, Dhurvas Chandrasekaran Dinesh, Pavel Srb, Evzen Boura, Vaclav Veverka, Jan Šilhán
Model of abasic site DNA cross-link repair; from the architecture of NEIL3 DNA binding domains to the X-structure model. Nucleic acids research 50 (18) (2022)
Bara Cihlova, Andrea Huskova, Jiri Böserle, Radim Nencka, Evzen Boura, Jan Šilhán
High-Throughput Fluorescent Assay for Inhibitor Screening of Proteases from RNA Viruses. Molecules (Basel, Switzerland) 26 (13) (2021)
Barbora Landová, Jan Šilhán
Conformational changes of DNA repair glycosylase MutM triggered by DNA binding. FEBS letters 594 (18) (2020)